Signos
Signal active
Organization
Contact Information
Overview
Signos is on a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight or obese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life
About
Industries
Machine Learning, Health Care
Founded
2018
Employees
11-50
Headquarters locations
Burlingame, California, United States, North America
Social
Profile Resume
Signos headquartered in United States, North America, operates in the Machine Learning, Health Care sector. The company focuses on Machine Learning and has secured $888.0M in funding across 24 round(s). With a team of 11-50 employees, Signos is actively contributing to advancements in Machine Learning. Their latest funding round, Series B - Signos, raised $20.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
6
Lead Investors
0
Total Funding Amount
$37.0M
Details
3
Signos has raised a total of $37.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 13.0M | ||
| 2021 | Seed | 4.0M | ||
| 2023 | Early Stage Venture | 20.0M |
Investors
Signos is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Dexcom Ventures | - | FUNDING ROUND - Dexcom Ventures | 20.0M |
| Julian Aiken | - | FUNDING ROUND - Julian Aiken | 20.0M |
| Signos | - | FUNDING ROUND - Signos | 20.0M |
| Romello Crowell | - | FUNDING ROUND - Romello Crowell | 20.0M |